Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740

Neuroscience

Volumn 250, Issue , 2013, Pages 189-200

  Procaccini, C ^a   Maksimovic, M ^a   Aitta aho, T ^a   Korpi, E R ^a   Linden, A M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

AMPA receptor; Hippocampus; Hyperlocomotion; Immediate early genes; MGlu2 3 receptor; Novelty

Indexed keywords

EGLUMETAD; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HYPERACTIVITY; HYPERLOCOMOTION; LOCOMOTION; MALE; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; SEX DIFFERENCE; TREATMENT RESPONSE;

(1S,2S,5R,6S)-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID; 2,3-DIOXO-6-NITRO-1,2,3,4-TETRAHYDROBENZO(F)QUINOXALINE-7-SULFONAMIDE; AMPA; AMPA RECEPTOR; ANALYSIS OF VARIANCE; ANOVA; BOVINE SERUM ALBUMIN; BSA; DENTATE GYRUS; DG; EAAT1/GLAST; EXCITATORY AMINO ACID TRANSPORTER 1; HIPPOCAMPUS; HYPERLOCOMOTION; IMMEDIATE EARLY GENES; KNOCKOUT; KO; LY354740; METABOTROPIC GLUTAMATE RECEPTORS; MGLU2/3 RECEPTOR; MGLUR; NBQX; NOVELTY; TBS; TBS SUPPLEMENTED WITH 0.05% TWEEN 20; TBST; TRIS-BUFFERED SALINE; WILDTYPE; WT; Α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID;

ANALYSIS OF VARIANCE; ANIMALS; BICYCLO COMPOUNDS; ENVIRONMENT; FEMALE; GENES, FOS; GENOTYPE; HIPPOCAMPUS; HYPERKINESIS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; SEX CHARACTERISTICS;

EID: 84881525518     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.010     Document Type: Article

References (73)

1. Aitta-aho T., Vekovischeva O.Y., Neuvonen P.J., Korpi E.R. Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice. Pharmacol Biochem Behav 2009, 92:283-290.
2. Aitta-aho T., Moykkynen T.P., Panhelainen A.E., Vekovischeva O.Y., Backstrom P., Korpi E.R. Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency. PLoS One 2012, 7:e38325.
3. Andrasfalvy B.K., Smith M.A., Borchardt T., Sprengel R., Magee J.C. Impaired regulation of synaptic strength in hippocampal neurons from GluR1-deficient mice. J Physiol 2003, 552:35-45.
4. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev 1999, 29:83-120.
5. Barkus C., Feyder M., Graybeal C., Wright T., Wiedholz L., Izquierdo A., Kiselycznyk C., Schmitt W., Sanderson D.J., Rawlins J.N., Saksida L.M., Bussey T.J., Sprengel R., Bannerman D., Holmes A. Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?. Neuropharmacology 2012, 62:1263-1272.
6. Boulware M.I., Weick J.P., Becklund B.R., Kuo S.P., Groth R.D., Mermelstein P.G. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 2005, 25:5066-5078.
7. Capogna M. Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs. Eur J Neurosci 2004, 19:2847-2858.
8. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 2000, 75:889-907.
9. Cartmell J., Monn J., Schoepp D. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 1999, 291:161-170.
10. Ceolin L., Kantamneni S., Barker G.R., Hanna L., Murray L., Warburton E.C., Robinson E.S., Monn J.A., Fitzjohn S.M., Collingridge G.L., Bortolotto Z.A., Lodge D. Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype. J Neurosci 2011, 31:6721-6731.
11. Chaban V., Li J., McDonald J.S., Rapkin A., Micevych P. Estradiol attenuates the adenosine triphosphate-induced increase of intracellular calcium through group II metabotropic glutamate receptors in rat dorsal root ganglion neurons. J Neurosci Res 2011, 89:1707-1710.
12. Chourbaji S., Vogt M.A., Fumagalli F., Sohr R., Frasca A., Brandwein C., Hortnagl H., Riva M.A., Sprengel R., Gass P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 2008, 22:3129-3134.
13. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997, 37:205-237.
14. Dachtler J., Fox K.D., Good M.A. Gender specific requirement of GluR1 receptors in contextual conditioning but not spatial learning. Neurobiol Learn Mem 2011, 96:461-467.
15. Day H.E., Nebel S., Sasse S., Campeau S. Inhibition of the central extended amygdala by loud noise and restraint stress. Eur J Neurosci 2005, 21:441-454.
16. Dunayevich E., Erickson J., Levine L., Landbloom R., Schoepp D.D., Tollefson G.D. Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology 2008, 33:1603-1610.
17. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65:7-19.
18. Fell M.J., Svensson K.A., Johnson B.G., Schoepp D.D. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 2008, 326:209-217.
19. Fell M.J., Katner J.S., Johnson B.G., Khilevich A., Schkeryantz J.M., Perry K.W., Svensson K.A. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge. Neuropharmacology 2010, 58:632-639.
20. Fell M.J., McKinzie D.L., Monn J.A., Svensson K.A. Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia. Neuropharmacology 2012, 62:1473-1483.
21. Field J.R., Walker A.G., Conn P.J. Targeting glutamate synapses in schizophrenia. Trends Mol Med 2011, 17:689-698.
22. Fitzgerald P.J., Barkus C., Feyder M., Wiedholz L.M., Chen Y.C., Karlsson R.M., Machado-Vieira R., Graybeal C., Sharp T., Zarate C., Harvey-White J., Du J., Sprengel R., Gass P., Bannerman D., Holmes A. Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?. Neurobiol Dis 2010, 40:608-621.
23. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 2007, Academic Press, New York.
24. Freudenberg F., Marx V., Mack V., Layer L.E., Klugmann M., Seeburg P.H., Sprengel R., Celikel T. GluA1 and its PDZ-interaction: a role in experience-dependent behavioral plasticity in the forced swim test. Neurobiol Dis 2013, 52:160-167.
25. Fumagalli F., Caffino L., Vogt M.A., Frasca A., Racagni G., Sprengel R., Gass P., Riva M.A. AMPA GluR-A receptor subunit mediates hippocampal responsiveness in mice exposed to stress. Hippocampus 2011, 21:1028-1035.
26. Giocomo L.M., Hasselmo M.E. Difference in time course of modulation of synaptic transmission by group II versus group III metabotropic glutamate receptors in region CA1 of the hippocampus. Hippocampus 2006, 16:1004-1016.
27. Grove-Strawser D., Boulware M.I., Mermelstein P.G. Membrane estrogen receptors activate metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 2010, 170:1045-1055.
28. Higgins G.A., Ballard T.M., Kew J.N., Richards J.G., Kemp J.A., Adam G., Woltering T., Nakanishi S., Mutel V. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004, 46:907-917.
29. Hoffman D.A., Sprengel R., Sakmann B. Molecular dissection of hippocampal theta-burst pairing potentiation. Proc Natl Acad Sci U S A 2002, A99:7740-7745.
30. Hu Y., Wu D.L., Luo C.X., Zhu L.J., Zhang J., Wu H.Y., Zhu D.Y. Hippocampal nitric oxide contributes to sex difference in affective behaviors. Proc Natl Acad Sci U S A 2012, 109:14224-14229.
31. Hurst J.L., West R.S. Taming anxiety in laboratory mice. Nat Methods 2010, 7:825-826.
32. Inta D., Monyer H., Sprengel R., Meyer-Lindenberg A., Gass P. Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review. Neurosci Biobehav Rev 2010, 34:285-294.
33. Jensen V., Kaiser K.M., Borchardt T., Adelmann G., Rozov A., Burnashev N., Brix C., Frotscher M., Andersen P., Hvalby O., Sakmann B., Seeburg P.H., Sprengel R. A juvenile form of postsynaptic hippocampal long-term potentiation in mice deficient for the AMPA receptor subunit GluR-A. J Physiol 2003, 553:843-856.
34. Kamiya H., Shinozaki H., Yamamoto C. Activation of metabotropic glutamate receptor type 2/3 suppresses transmission at rat hippocampal mossy fibre synapses. J Physiol 1996, 493:447-455.
35. Karlsson R.M., Tanaka K., Heilig M., Holmes A. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol Psychiatry 2008, 64:810-814.
36. Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakmann B., Seeburg P.H. A family of AMPA-selective glutamate receptors. Science 1990, 249:556-560.
37. Kew J.N., Ducarre J.M., Pflimlin M.C., Mutel V., Kemp J.A. Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1. Neuropharmacology 2001, 40:20-27.
38. Kew J.N.C., Pflimlin M.C., Kemp J.A., Mutel V. Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice. Neuropharmacology 2002, 43:215-221.
39. Kilbride J., Huang L.Q., Rowan M.J., Anwyl R. Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV. Eur J Pharmacol 1998, 356:149-157.
40. Kubik S., Miyashita T., Guzowski J.F. Using immediate-early genes to map hippocampal subregional functions. Learn Mem 2007, 14:758-770.
41. Linden A.M., Greene S.J., Bergeron M., Schoepp D.D. Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology 2004, 29:502-513.
42. Linden A.M., Bergeron M., Schoepp D.D. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo. Neuropharmacology 2005, 49:120-134.
43. Linden A.M., Shannon H., Baez M., Yu J.L., Koester A., Schoepp D.D. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology (Berl) 2005, 179:284-291.
44. Longordo F., Fan J., Steimer T., Kopp C., Luthi A. Do mice habituate to "gentle handling"? A comparison of resting behavior, corticosterone levels and synaptic function in handled and undisturbed C57BL/6J mice. Sleep 2011, 34:679-681.
45. Lorrain D., Schaffhauser H., Cambell U., Baccei C., Correa L., Rowe B., Rodriguez D., Anderson J., Varney M., Pinkerton A., Vernier J.M., Bristow L. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor reponses to acute ketamine challenge. Neuropsychopharmacology 2003, 28:1622-1632.
46. Macek T.A., Winder D.G., Gereau R.Wt., Ladd C.O., Conn P.J. Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses. J Neurophysiol 1996, 76:3798-3806.
47. Malkani S., Rosen J.B. Differential expression of EGR-1 mRNA in the amygdala following diazepam in contextual fear conditioning. Brain Res 2000, 860:53-63.
48. Marek G.J. Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition. Eur J Pharmacol 2010, 639:81-90.
49. Moghaddam B., Adams B. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281:1349-1352.
50. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 1997, 40:528-537.
51. Patil S.T., Zhang L., Martenyi F., Lowe S.L., Jackson K.A., Andreev B.V., Avedisova A.S., Bardenstein L.M., Gurovich I.Y., Morozova M.A., Mosolov S.N., Neznanov N.G., Reznik A.M., Smulevich A.B., Tochilov V.A., Johnson B.G., Monn J.A., Schoepp D.D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007, 13:1102-1107.
52. Phillips K.G., Hardingham N.R., Fox K. Postsynaptic action potentials are required for nitric-oxide-dependent long-term potentiation in CA1 neurons of adult GluR1 knock-out and wild-type mice. J Neurosci 2008, 28:14031-14041.
53. Price C.J., Karayannis T., Pal B.Z., Capogna M. Group II and III mGluRs-mediated presynaptic inhibition of EPSCs recorded from hippocampal interneurons of CA1 stratum lacunosum moleculare. Neuropharmacology 2005, 49:45-56.
54. Procaccini C., Aitta-aho T., Jaako-Movits K., Zharkovsky A., Panhelainen A., Sprengel R., Linden A.M., Korpi E.R. Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice. Eur J Neurosci 2011, 33:161-174.
55. Reisel D., Bannerman D.M., Schmitt W.B., Deacon R.M., Flint J., Borchardt T., Seeburg P.H., Rawlins J.N. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci 2002, 5:868-873.
56. Romberg C., Raffel J., Martin L., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M., Paulsen O. Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus. Eur J Neurosci 2009, 29:1141-1152.
57. Ryabinin A.E., Wang Y.M., Finn D.A. Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav 1999, 63:143-151.
58. Sanderson D.J., Good M.A., Skelton K., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem 2009, 16:379-386.
59. Scanziani M., Salin P.A., Vogt K.E., Malenka R.C., Nicoll R.A. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature 1997, 385:630-634.
60. Schmitt W.B., Deacon R.M., Seeburg P.H., Rawlins J.N., Bannerman D.M. A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice. J Neurosci 2003, 23:3953-3959.
61. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 1997, 17:7503-7522.
62. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 2005, 4:131-144.
63. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010, 62:405-496.
64. VanElzakker M., Fevurly R.D., Breindel T., Spencer R.L. Environmental novelty is associated with a selective increase in Fos expression in the output elements of the hippocampal formation and the perirhinal cortex. Learn Mem 2008, 15:899-908.
65. Vekovischeva O.Y., Zamanillo D., Echenko O., Seppala T., Uusi-Oukari M., Honkanen A., Seeburg P.H., Sprengel R., Korpi E.R. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J Neurosci 2001, 21:4451-4459.
66. Vekovischeva O.Y., Aitta-Aho T., Echenko O., Kankaanpaa A., Seppala T., Honkanen A., Sprengel R., Korpi E.R. Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice. Genes Brain Behav 2004, 3:253-265.
67. Wiedholz L.M., Owens W.A., Horton R.E., Feyder M., Karlsson R.M., Hefner K., Sprengel R., Celikel T., Daws L.C., Holmes A. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry 2008, 13:631-640.
68. Wischhof L., Koch M. Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression. Psychopharmacology (Berl) 2012, 219:387-400.
69. 3H]LY459477 autoradiography. Neuropharmacology 2013, 66:89-98.
70. Yokoi M., Kobayashi K., Manabe T., Takahashi T., Sakaguchi I., Katsuura G., Shigemoto R., Ohishi H., Nomura S., Nakamura K., Nakao K., Katsuki M., Nakanishi S. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science 1996, 273:645-647.
71. Zamanillo D., Sprengel R., Hvalby O., Jensen V., Burnashev N., Rozov A., Kaiser K.M., Koster H.J., Borchardt T., Worley P., Lubke J., Frotscher M., Kelly P.H., Sommer B., Andersen P., Seeburg P.H., Sakmann B. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999, 284:1805-1811.
72. Zhao Y., Dayas C.V., Aujla H., Baptista M.A., Martin-Fardon R., Weiss F. Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J Neurosci 2006, 26:9967-9974.
73. Zuena A.R., Mairesse J., Casolini P., Cinque C., Alema G.S., Morley-Fletcher S., Chiodi V., Spagnoli L.G., Gradini R., Catalani A., Nicoletti F., Maccari S. Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One 2008, 3:e2170.